Clinical trial · Observational
Associations Among Serum and Gastric Juice Bile Acid Profile, Bile Acid-microbiota Cross-talk in Stomach and the Development of Gastric Cancer
Associations Among Serum and Gastric Juice Bile Acid Profile, Bile Acid-microbiota Cross-talk in Stomach and the Development of Gastric Cancer: A Case-control Study
NCT04660058CI-TRIAL-00063565completedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
To explore the associations among bile acid profile, bile acid-microbiota cross-talk and the development of gastric cancer, so as to better prevent the occurrence and development of gastric cancer
Conditions
Conditions (3)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Bile Reflux | — | UNRESOLVED | — |
| Gastric Cancer | Malignant Gastric Neoplasm | CURATED_BROADER | 0.80 |
| Precancerous Lesion | — | UNRESOLVED | — |
Interventions
Interventions (0)
Data not yet available
No intervention recorded.
Design
Arms and outcomes
Arms (3)
- label
- chronic gastritis
- description
- patients with chronic non-atrophic gastritis and chronic atrophic gastritis according to histopathological results
- label
- precancerous lesion
- description
- patients with gastric intestinal metaplasia and intraepithelial neoplasia according to histopathological results
- label
- gastric cancer
- description
- patients with gastric cancer according to histopathological results
Primary outcomes (2)
- measure
- corelation between the bile acid profile and gastric mucosa diseases
- timeFrame
- up to 6 months
- description
- Investigators evaluate the corelation between the bile acid profile and gastric mucosa diseases according to the results of UPLC-MS/MS and pathological .
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
- Maximum age
- 75 Years
Show eligibility criteria text
Inclusion Criteria: 1. Age 18 to 75 years old, gender is not limited; 2. No history of antibiotic or probiotic use for 8 weeks; 3. No preoperative chemotherapy or radiation therapy prior to the examination; 4. Voluntary intravenous blood collection, gastroscopy, extraction of gastric juice and pathological biopsy. 5. Voluntary testing for H. pylori Exclusion Criteria: 1. had undergone upper gastrointestinal and colon surgery; 2. Previous diagnosis of Malignant Tumors; 3. Presence of a disease or medication that affects bile acid metabolism, such as endocrine or autoimmune diseases; 4. Recent use of drugs that affect gastrointestinal motility; 5. Presence of contraindications to endoscopy; 6. pregnant and lactating women; 7. Those with mental disorders; 8. Refusal to sign the informed consent form.
References
Publications (0)
Data not yet available
No reference posted for this study.